Produkty 10455-93-3

CAS 10455-93-3 występuje w naszej ofercie pod nazwami: 17-Hydroxy-5Beta-pregnane-3,11,20-trione, 17-Hydroxy-5b-pregnane-3,11,20-trione. Oferty producentów: TRC. Dostępne opakowania: 100mg, 250mg, 25mg.

17-Hydroxy-5Beta-pregnane-3,11,20-trione
TRC
  • opakowanie: 100mg, 25mg
  • Warianty: 2
Zobacz produkt
17-Hydroxy-5b-pregnane-3,11,20-trione
TRC
  • opakowanie: 250mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(5R,8S,9S,10S,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione (CAS 10455-93-3) to związek chemiczny o wzorze sumarycznym C21H30O4 i masie molowej 346.5 g/mol. Nazwa systematyczna IUPAC: (5R,8S,9S,10S,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione. InChIKey: QFXXVTGREOEPLZ-QHDBMQRRSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H30O4
Masa molowa346.5 g/mol
Nazwa IUPAC(5R,8S,9S,10S,13S,14S,17R)-17-acetyl-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthrene-3,11-dione
InChIKeyQFXXVTGREOEPLZ-QHDBMQRRSA-N
SMILESCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 17-Hydroxy-5beta-pregnane-3,11,20-trione, 5beta-Pregnane-17alpha-ol-3,11,20-trione, 5.beta.-Pregnane-3,20-trione, 17-hydroxy-, 17alpha-hydroxy-5beta-Pregnane-3,11,20-trione
Izomery (ten sam wzór sumaryczny)
(9S,10S)-6,6,9-trimethyl-3-pentyl-8,10-dihydro-7H-benzo[c]chromene-1,9,10-triol C21H30O4
[(1S,2S,4R,6S,8S,11R,12S,14R,16R,17S)-2,17-dimethyl-5,15-dioxahexacyclo[9.8.0.02,8.04,6.012,17.014,16]nonadecan-16-yl] acetate C21H30O4
(8R,9S,10R,13S,14S,16R,17S)-17-acetyl-16,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11S,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8R,9S,10R,13S,14S,17R)-17-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11R,13S,14S,17R)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
(8S,9S,10R,11R,13S,14S,17S)-11,17-dihydroxy-2-(hydroxymethyl)-10,13,17-trimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one C21H30O4
(6R,8R,9S,10R,13S,14S,17R)-17-acetyl-6,17-dihydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one C21H30O4
3-methyl-1-[2,4,6-trihydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]butan-1-one C21H30O4
[(3S,7R,8R,9S,10R,13S,14S)-7-hydroxy-10,13-dimethyl-17-oxo-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate C21H30O4
[(6R,8R,9R,10S,13S,14S,17S)-6-hydroxy-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl] acetate C21H30O4